Latest SPAC Liquidations: Thrive, Medicus Sciences
Thrive Acquisition Corp. (THAC) to Liquidate on January 25
Thrive Acquisition Corporation (NASDAQ: THAC) announced today that it intends to liquidate and dissolve, effective as of the close of business on January 25, 2023, and will redeem all of the outstanding Class A ordinary shares at an anticipated per-share redemption price of approximately $10.36.READ
Medicus Sciences Acquisition Corp. (MSAC) Announces Intent to Liquidate
On January 11, 2023, Medicus Sciences Acquisition Corp. (NASDAQ:MSAC) received a notice of failure to satisfy a continued listing standard from Nasdaq.
The notice indicated that the company failed to hold an annual meeting of shareholders within the required twelve-month period for the fiscal year ended December 31, 2022.
Failure to regain compliance with standards for continued listing would result in the ultimate de-listing of the company’s Class A ordinary shares, ticker symbol “MSAC”, from Nasdaq. Because it is unlikely Medicus will be able to complete a business combination before its completion deadline of February 18, 2023, the company intends to liquidate promptly after the deadline and therefore will not submit a plan of compliance.READ